Cure My Disease

Don't miss your cure!

 Log in / Sign up

New asthma drug shows promise in Real-World study

NCT ID NCT06422078

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 24 times

Summary

This study follows 300 adults with severe eosinophilic asthma who are prescribed benralizumab as part of their normal care. Researchers will track asthma control, quality of life, lung function, and medication use over a year to see how well the drug works in everyday settings. The goal is to understand if benralizumab helps patients achieve better asthma control and reduce their need for other medications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA, BRONCHIAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Ahrensburg, Germany

  • Research Site

    RECRUITING

    Ansbach, Germany

  • Research Site

    RECRUITING

    Aschaffenburg, Germany

  • Research Site

    RECRUITING

    Auerbach, Germany

  • Research Site

    RECRUITING

    Augsburg, Germany

  • Research Site

    RECRUITING

    Bad Homburg, Germany

  • Research Site

    RECRUITING

    Berlin, Germany

  • Research Site

    RECRUITING

    Cottbus, Germany

  • Research Site

    RECRUITING

    Darmstadt, Germany

  • Research Site

    RECRUITING

    Dresden, Germany

  • Research Site

    RECRUITING

    Düsseldorf, Germany

  • Research Site

    RECRUITING

    Ehringshausen, Germany

  • Research Site

    RECRUITING

    Erkelenz, Germany

  • Research Site

    RECRUITING

    Essen, Germany

  • Research Site

    RECRUITING

    Flensburg, Germany

  • Research Site

    RECRUITING

    Frankfurt am Main, Germany

  • Research Site

    RECRUITING

    Garmisch-Partenkirchen, Germany

  • Research Site

    RECRUITING

    Halle, Germany

  • Research Site

    RECRUITING

    Hamburg, Germany

  • Research Site

    RECRUITING

    Hanover, Germany

  • Research Site

    WITHDRAWN

    Heidelberg, Germany

  • Research Site

    RECRUITING

    Heidelberg, Germany

  • Research Site

    RECRUITING

    Hohenstein-Ernsttahl, Germany

  • Research Site

    RECRUITING

    Itzehoe, Germany

  • Research Site

    RECRUITING

    Jena, Germany

  • Research Site

    RECRUITING

    Leipzig, Germany

  • Research Site

    RECRUITING

    Loerrach, Germany

  • Research Site

    RECRUITING

    Lübeck, Germany

  • Research Site

    RECRUITING

    Lüneburg, Germany

  • Research Site

    RECRUITING

    Markkleeberg, Germany

  • Research Site

    RECRUITING

    Mönchengladbach, Germany

  • Research Site

    RECRUITING

    Neuruppin, Germany

  • Research Site

    RECRUITING

    Nuremberg, Germany

  • Research Site

    RECRUITING

    Papenburg, Germany

  • Research Site

    RECRUITING

    Rostock, Germany

  • Research Site

    RECRUITING

    Saalfeld, Germany

  • Research Site

    RECRUITING

    Spardorf, Germany

  • Research Site

    RECRUITING

    Weißenburg, Germany

  • Research Site

    RECRUITING

    Wilhelmshaven, Germany

  • Research Site

    RECRUITING

    Würzburg, Germany

  • Research Site

    RECRUITING

    Zossen, Germany

Conditions

Explore the condition pages connected to this study.

ASTHMA, BRONCHIAL